These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3808127)

  • 1. The value of the short term predictive assay in the inductive treatment of patients with acute nonlymphoblastic leukemia.
    Mardiak J; Ujházy V
    Neoplasma; 1986; 33(6):723-30. PubMed ID: 3808127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
    Cassileth PA; Kahn SB; Silber R; Weiler C
    Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemia.
    Saccardi R; Bernabei PA; Bezzini R; Agostino FC; Leoni F; Rossi Ferrini P
    Chemioterapia; 1988 Jun; 7(3):173-8. PubMed ID: 3168072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of PTT 119 activity on acute nonlymphoblastic leukemia cells by [3H]-thymidine uptake inhibition and cluster analysis.
    Dal Pozzo O; Santini V; Saccardi R; Bernabei PA; Rossi Ferrini P
    Haematologica; 1990; 75(1):50-3. PubMed ID: 2338287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy for acute nonlymphoblastic leukemia in adults.
    Glucksberg H; Buckner CD; Fefer A; DeMarsh Q; Coleman D; Dobrow RB; Huff J; Kjobech C; Hill AS; Dittman W; Neiman PE; Cheever MA; Einstein AB; Thomas ED
    Cancer Chemother Rep; 1975; 59(6):1131-7. PubMed ID: 769952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of acute leukemia. Opinion of Prof. Franco Mandelli].
    Salvati A
    Minerva Med; 1973 Jan; 64(4):170-2. PubMed ID: 4510268
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
    Armitage JO; Burns CP; Dick FR; Aunan SB; Slymen DJ
    Cancer Treat Rep; 1982 Nov; 66(11):1917-24. PubMed ID: 7139637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 13. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognosis of acute leukaemia in adults.
    Penington DG; Keating MJ
    Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.
    Poth JL; Johnson PK; George RP; Schrier SL
    Calif Med; 1972 Dec; 117(6):1-11. PubMed ID: 4508367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
    Stavem P; Gjemdal T
    Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of acute leukoses].
    Stacher A
    Wien Med Wochenschr; 1973 Sep; 123(38):549-54. PubMed ID: 4201578
    [No Abstract]   [Full Text] [Related]  

  • 18. A short-term chemosensitivity test with different labeled precursors of DNA or protein synthesis: correlation with clinical response.
    Viano I; Silvestro L; Infelise V; Falda M; Lovisone E; Compagnoni G; Genazzani E
    Tumori; 1986 Aug; 72(4):357-63. PubMed ID: 3464124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of acute nonlymphocytic leukemia induction chemotherapy in acute lymphocytic leukemia.
    Cassileth PA; Bennett JM
    Cancer Treat Rep; 1985 Dec; 69(12):1439-40. PubMed ID: 3865702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.